Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B
S. Sanlioglu et al., Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B, J BIOL CHEM, 276(32), 2001, pp. 30188-30198
Reactive oxygen species (ROS) are important second messengers generated in
response to many types of environmental stress. In this setting, changes in
intracellular ROS can activate signal transduction pathways that influence
how cells react to their environment. In sepsis, a dynamic proinflammatory
cellular response to bacterial toxins (e.g., lipopolysaccharide or LPS) le
ads to widespread organ damage and death. The present study demonstrates fo
r the first time that the activation of Rac1 (a GTP-binding protein), and t
he subsequent production of ROS, constitutes a major pathway involved in NF
kappaB-mediated tumor necrosis factor-alpha (TNF alpha) secretion followin
g LPS challenge in macrophages. Expression of a dominant negative mutant of
Rac1. (N17Rac1) reduced Rac1 activation, ROS formation, NF kappaB activati
on, and TNF alpha secretion following LPS stimulation. In contrast, express
ion of a dominant active form of Rac1 (V12Rac1) mimicked these effects in t
he absence of LPS stimulation. IKK alpha and IKK beta were both required do
wnstream modulators of LPS-activated Rac1, since the expression of either o
f the IKK dominant mutants (IKK alpha KM or IKK beta KA) drastically reduce
d NF kappaB-dependent TNF alpha secretion. Moreover, studies using CD14 blo
cking antibodies suggest that Rac1 induces TNF alpha secretion through a pa
thway independent of CD14. However, a maximum therapeutic inhibition of LPS
-induced TNF alpha secretion occurred when both CD14 and Rac1 pathways were
inhibited. Our results suggest that targeting both Rac1- and CD14-dependen
t pathways could be a useful therapeutic strategy for attenuating the proin
flammatory cytokine response during the course of sepsis.